Date: December 6-7, 2021

Venue: Boston, MA

Reimbursement executives attempt to comply with stringent commercial and public payer standards as the diagnostic industry evolves and expands into ever more specialized areas of testing. Provisions and specific evidence required to ensure coverage are always evolving, but the technology appears to be progressing even faster, posing unique hurdles in showing product value and integrating innovative diagnostics into existing payment schemes.

The Diagnostic Coverage & Reimbursement conference has brought together more than 1200 industry professionals over the last ten years to discuss crucial challenges affecting diagnostic technology pricing, allowing the industry to better integrate breakthrough tests into the healthcare sector.

Topics will include:

• A Look at the Evolving Contracting & Pricing from the Payer’s Perspective Landscape
• Evaluating Health Policy and Coverage Requirements from the Payer Perspective Panel Landscape
• Putting in Place Effective Appeals Process Planning and Execution
• Administration & Legislative Guidance in Forecasting Diagnostic Tests News and Updates

The Q1 Productions Diagnostic Coverage & Reimbursement Conference will provide attendees with targeted insight into the most pressing challenges in obtaining satisfactory payments, as well as a forward-focused look at rising industry trends and their implications for reimbursement efforts in the future editions. 

This conference provides an unrivaled chance for delegates to maximize methods to drive successful payment by sharing thoughts on diagnostics’ place within value-based frameworks and the possibilities for new income streams by engaging with pharmaceutical firms.

Attendees will engage in peer-to-peer knowledge sharing while also benefiting from direct insight into payer perspectives on coverage and payment from a variety of perspectives, including small and big manufacturers, laboratories, and public and private payers.

Why is it important?

The attendees will gain firsthand insight into current solutions through a unique encounter with expert thinking leaders. You’ll learn about current subjects directly connected to your sector through lively panel discussions, case studies, and real-world proof. Your team has access to a platform where they may ask questions of experienced industry professionals. 

It’s a great opportunity to expand your knowledge and perceive things in a new light. You and your team will have access to insight and interaction. Collaborate with your peers to overcome common difficulties by drawing on their knowledge and expertise.

This in-person event connects you with public and private payers for direct insight into policy creation and decision-making frameworks, allowing you to extend product coverage successfully. During Q&A after peer-led case studies and success stories, avoid errors, increase market access through lessons learned, and collaborate on solutions. In engaging discussion-based sessions, build ties with decision-makers as well as diagnostic industry peers.

For more information, please visit https://ibn.fm/BcNaZ

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.